Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ProMIS Neurosciences Inc.

    NASDAQ: PMN · Real-Time Price · USD
    0.50
    -0.01 (-2.53%)
    At close: Jun 17, 2025, 3:55 PM
    0.50
    -0.70%
    After-hours: Jun 17, 2025, 04:00 PM EDT

    ProMIS Neurosciences Statistics

    Share Statistics

    ProMIS Neurosciences has 32.69M shares outstanding. The number of shares has increased by 72.4% in one year.

    Shares Outstanding

    n/a
    		 32.69M

    Shares Change (YoY)

    n/a
    		 72.4%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 23.03M

    Failed to Deliver (FTD) Shares

    n/a
    		 60,235

    FTD / Avg. Volume

    n/a
    		 139.27%

    Short Selling Information

    The latest short interest is 167.98K, so 0.51% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 167.98K

    Short % of Shares Out

    n/a
    		 0.51%

    Short % of Float

    n/a
    		 0.52%

    Short Ratio (days to cover)

    n/a
    		 3.92

    Valuation Ratios

    The PE ratio is 0.01 and the forward PE ratio is -0.66. ProMIS Neurosciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 0.01

    Forward PE

    n/a
    		 -0.66

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -0.9

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    ProMIS Neurosciences has an Enterprise Value (EV) of 11.28M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 0

    EV / EBIT

    n/a
    		 -0.41

    EV / FCF

    n/a
    		 -0.41

    Financial Position

    The company has a current ratio of 8.52, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 8.52

    Quick Ratio

    n/a
    		 8.52

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 219.18

    Financial Efficiency

    Return on Equity is 16.85% and Return on Invested Capital is -100805.41%.

    Return on Equity

    n/a
    		 16.85%

    Return on Assets

    n/a
    		 14694.13%

    Return on Invested Capital

    n/a
    		 -100805.41%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $396,981,857.14

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -65.79% in the last 52 weeks. The beta is -0.08, so ProMIS Neurosciences's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.08

    52-Week Price Change

    n/a
    		 -65.79%

    50-Day Moving Average

    n/a
    		 0.55

    200-Day Moving Average

    n/a
    		 0.87

    Relative Strength Index (RSI)

    n/a
    		 47.76

    Average Volume (20 Days)

    n/a
    		 43,249

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -16.83B

    Net Income

    n/a
    		 2.78B

    EBITDA

    n/a
    		 -16.83B

    EBIT

    n/a
    		 2.7B

    Earnings Per Share (EPS)

    n/a
    		 0.11
    Full Income Statement

    Balance Sheet

    The company has 13.29M in cash and 0 in debt, giving a net cash position of 13.29M.

    Cash & Cash Equivalents

    n/a
    		 13.29M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -90.69B

    Total Assets

    n/a
    		 13.65M

    Working Capital

    n/a
    		 9.59M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -27.18M and capital expenditures 0, giving a free cash flow of -27.18M.

    Operating Cash Flow

    n/a
    		 -27.18M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -27.18M

    FCF Per Share

    n/a
    		 -1.05
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PMN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 11311.43%

    FCF Yield

    n/a
    		 -110.65%
    Dividend Details

    Analyst Forecast

    The average price target for PMN is $4.5, which is 765.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4.5

    Price Target Difference

    n/a
    		 765.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 1238.73

    Graham Upside

    n/a
    		 238117.31%

    Stock Splits

    The last stock split was on Jun 28, 2022. It was a backward split with a ratio of 1:60.

    Last Split Date

    n/a
    		 Jun 28, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:60

    Scores

    Altman Z-Score

    n/a
    		 -10.43

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist